News

Stay informed about our latest innovations, products and scientific news. Learn more about Eurofins CALIXAR through our press releases and biotech events and find out why we are at the forefront of protein technology.

Press releases
September 23, 2014

CALIXAR and VirPath develop an innovative manufacturing process for high performance influenza vaccines

Press releases
June 16, 2014

CALIXAR to extend its portfolio of strategic compounds for complex pharmaceutical target isolation

News
June 16, 2014

New Strategic Compounds

Related news
April 2, 2014

Lyon Première (FR)

News
March 11, 2014

Video presentation of CALIXAR

Related news
January 2, 2014

Agir et Entreprendre (FR)

News
December 12, 2013

CALIXAR, a rising star

Related news
December 12, 2013

Rhône Press (FR)

News
November 13, 2013

NETVA 2013 winners with Steve Blank @ K&S Ranch

News
October 16, 2013

CALIXAR joined the GDR3545 membership – GPCRs from physiology to drugs

Secure and boost
your discovery programs

Starting from native material or recombinant systems, we succeed with all types of proteins: Kinases, Phosphatases, Ubiquitins, Epigenetic Proteins, GPCRs, Ion Channels, Transporters, Receptors and Viral Proteins.